InnovAge Holding Corp. Common Stock (INNV) is a publicly traded Healthcare sector company. As of May 21, 2026, INNV trades at $7.51 with a market cap of $984.09M and a P/E ratio of -93.06. INNV moved +4.30% today. Year to date, INNV is +37.04%; over the trailing twelve months it is +77.12%. Its 52-week range spans $2.60 to $10.69. Analyst consensus is sell with an average price target of $7.00. Rallies surfaces INNV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes INNV SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $7.51 |
| Market Cap | $984.09M |
| P/E Ratio | -93.06 |
| EPS | $-0.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.69 |
| 52-Week Low | $2.60 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $949.17M |
| Net Income | $-15.47M |
| Gross Margin | 21.75% |
3 analysts cover INNV: 0 strong buy, 0 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $7.00.